Intestinal Perforation after Bevacizumab Treatment in Metastatic Colon Cancer: A Rare Case
Öz
Bevacizumab is a monoclonal antibody which is targeting to vascular endothelial growth factor. It has been shown to be a promising drug on metastatic colorectal cancer and is combined with chemotherapeutic agents. One should be aware of serious complications even though bevacizumab is a well-tolerated drug. There are a few intestinal perforation cases that have been reported in the oncologic surgery literature related to the bevacizumab treatment. In this case report, we aimed to represent a 45 years old man who was diagnosed with intestinal perforation after bevacizumab treatment ten months after a metastatic colon cancer surgery.
Key words: Bevacizumab, intestinal perforation, metastatic colorectal cancer
Anahtar Kelimeler
Kaynakça
- Shih T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 2006;28:1779- 1802.
- Bernold DM, Sinicrope FA. Advances in chemotherapy for colorectal cancer. Clin Gastroenterol Hepatol 2006;4:808-821.
- Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335-2342.
- Chen HX, Mooney M, Boron M, et al. Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301. J Clin Oncol 2006; 24:3354-3360.
- Jain RK. Normalizing tumor vasculature with antiangiogenic therapy: a new paradigm for combination therapy. Nat Med 2001;7:987-989.
- Shord SS, Bressler LR, Tierney LA, et al. Understanding and managing the possible adverse effects associated with bevacizumab.
- Am J Health Syst Pharm 2009; 66:999-1013.
- Saif MW, Elfiky A, Salem RR. Gastrointestinal perforation due to bevacizumab in colorectal cancer. Ann Surg Oncol 2007;14:1860-869.
Ayrıntılar
Birincil Dil
Türkçe
Konular
-
Bölüm
-
Yazarlar
Durmuş Çetin
Bu kişi benim
Ebubekir Gündeş
Bu kişi benim
Ulaş Aday
Bu kişi benim
Hüseyin Çiyiltepe
Bu kişi benim
Kamuran Değer
Bu kişi benim
Mustafa Duman
Bu kişi benim
Yayımlanma Tarihi
1 Mart 2016
Gönderilme Tarihi
29 Mart 2016
Kabul Tarihi
-
Yayımlandığı Sayı
Yıl 2016 Cilt: 43 Sayı: 1
Cited By
PARMAK İZİ KAYBINA NEDEN OLAN KANSER İLAÇLARINA GENEL BAKIŞ
Doğu Karadeniz Sağlık Bilimleri Dergisi
https://doi.org/10.59312/ebshealth.1376750